VAXXA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.735 SEK | -1.34% |
|
-8.12% | -33.18% |
| 10/04 | Vaxxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 23/02 | Vaxxa AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
| Sales 2021 | 13.22L 1L 1.03Cr | Sales 2022 | 4.57Cr 42.55L 35Cr | Capitalization | 1.3Cr 12.09L 10Cr |
|---|---|---|---|---|---|
| Net income 2021 | -1.2Cr -11.18L -9.31Cr | Net income 2022 | -5.1Cr -47.51L -40Cr | EV / Sales 2021 | 14.4 x |
| Net cash position 2021 | 46.92L 4L 3.64Cr | Net cash position 2022 | 10.05L 93.63T 77.96L | EV / Sales 2022 | 0.26 x |
| P/E ratio 2021 |
-1.95
x | P/E ratio 2022 |
-0.25
x | Employees | 5 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.34% | ||
| 1 week | -8.12% | ||
| Current month | -16.00% | ||
| 1 month | -14.14% | ||
| 3 months | -31.94% | ||
| 6 months | -18.33% | ||
| Current year | -33.18% |
1 week
0.70
0.79
1 month
0.701.00
Current year
0.701.30
1 year
0.605.30
3 years
0.6072.70
5 years
0.60195.50
10 years
0.601 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Karl Frindberg
CEO | Chief Executive Officer | 53 | 01/22/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Per Hägerö
CHM | Chairman | 52 | 01/16/01 |
Milad Pournouri
BRD | Director/Board Member | 30 | - |
Oliver Aleksov
BRD | Director/Board Member | 30 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/24/23 | 0.735 | -1.34% | 56,311 |
| 22/24/22 | 0.745 | +2.05% | 37,681 |
| 21/24/21 | 0.73 | -1.35% | 37,590 |
| 20/24/20 | 0.74 | -3.90% | 50,254 |
| 17/24/17 | 0.77 | 0.00% | 46,843 |
End-of-day quote NORDIC GROWTH MARKET, May 23, 2024
More quotes- Stock Market
- Equities
- VAXXA Stock
